Address
Email address
Euroapteek e-apteegist saate osta kosmeetikatooteid, toidulisandeid ja käsimüügiravimeid. Lisaks saate e-apteegist oste sooritada igal pool, Teile sobival ajal.
Name
OÜ PharmaEighteen
Registry code
16009799
VAT number
EE102272406
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
15.07.2020 (4)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
47731 - Dispensing chemist in specialised stores
2 654 699 €
-27 471 €
-1%
1 793 €
(estimate is approximate)
-61 540 €
2
Submitted
No tax arrears
45%
-5%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Omanikukonto: JEKATERINA JEFIMOVA 02.12.1956 (67) | 100% - 2 500.00 EUR | Board member | - | |
Osaühing EUROAPTEEK 11036389 | - | - | - | Founder |
2021 20.06.2022 | 2022 14.06.2023 | 2023 15.06.2024 | |
---|---|---|---|
Total Revenue | 2 284 190 € | 2 359 174 € | 2 654 699 € |
Net profit (loss) for the period | 20 684 € | -52 186 € | -27 471 € |
Profit Margin | 1% | -2% | -1% |
Current Assets | 351 359 € | 595 840 € | 407 480 € |
Fixed Assets | 630 257 € | 558 755 € | 202 155 € |
Total Assets | 981 616 € | 1 154 595 € | 609 635 € |
Current Liabilities | 963 499 € | 1 188 663 € | 671 175 € |
Non Current Liabilities | - | - | - |
Total Liabilities | - | - | - |
Share Capital | - | - | - |
Equity | 18 117 € | -34 068 € | -61 540 € |
Employees | 1 | 2 | 2 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 651 290.51 € | - | 5 762.75 € | 6 |
2023 Q4 | 650 298.93 € | - | 5 630.55 € | 5 |
2023 Q3 | 617 884.7 € | - | 4 890.94 € | 3 |
2023 Q2 | 687 427.15 € | - | 5 038.71 € | 3 |
2023 Q1 | 734 056.95 € | - | 4 575.31 € | 3 |
2022 Q4 | 616 335.41 € | - | 6 063.81 € | 3 |
2022 Q3 | 523 471.13 € | - | 5 908.42 € | 3 |
2022 Q2 | 556 067.94 € | - | 4 103.63 € | 2 |
2022 Q1 | 612 930.54 € | - | 3 864.38 € | 1 |
2021 Q4 | 620 968.13 € | - | 2 477.71 € | 1 |
2021 Q3 | 519 840.91 € | - | 4 380.97 € | 1 |
2021 Q2 | 572 422.69 € | 4 674.04 € | 3 561.86 € | 1 |
2021 Q1 | 571 319.49 € | 3 529.99 € | 3 240.71 € | 1 |
2020 Q4 | 196 024.19 € | - | - | 1 |
2020 Q3 | - | - | - | - |